Spirit Magazine (Southwest Airlines): Dollars and Sense. It may seem like a given, but some scientists assure us that deep-seeded emotions drive our investment decisions. That doesn't mean we always make the right moves. September. 2006.

Genetic Engineering News: Spotting Neurobiotech Developments.
The brain is poised to become the number-one target for drug development during the next decade. The recent Neurotech Investing and Business conference hosted by NeuroInsights featured scientists, executives and investors analyzing the critical factors driving the development of new drugs, devices and diagnostics for CNS disorders. July 2006.

Nature Biotechnology: Monoclonals Expand into Neural Disorders
In April, Pfizer bought a Genentech spinoff, Rinat Neuroscience, for "close to $500 million dollars," according to one source. What drew Pfizer's interest to Rinat was its pipeline, in particular, two of its most advanced drugs. June 2, 2006.

M&C News: Human Enhancement: Problem or Solution?
Since the advent of simple tools, humans have been expanding their capacities. Cognitive enhancement dates back to the written word, a primitive process for downloading information from our minds to the hard drive of parchment. June 2, 2006.

Science Business: Neurotechnology - The Next Frontier
With global revenues of $110 billion last year, and an aging population, the nascent "neurotechnology" market appears poised for huge growth. June 1, 2006.

MIT Technology Review: The Future of Neurotechnology
Neurotechnology expert Zack Lynch explains the new field and tells us what the future holds for treating brain disorders. May 25, 2006.

Neurotechnology Revenues Reach $110 Billion Says New Report on the Brain Industry:
NeuroInsights Reveals Investment Trends, Market Opportunities and Product Pipelines of 450 Neurotech Companies. NeuroInsights, the neurotechnology market authority, today announced the release of the industry's second annual comprehensive investment and business analysis of the global neurotechnology marketplace. April 18, 2006.

International Herald Tribune: Sex, Drugs, Money: The Pleasure Principle
The pleasure of orgasm, the high from cocaine, the rush of buying Google at $450 a share - the same neural network governs all three, Knutson, a professor of neuroscience and psychology, has concluded. What's more, our primal pleasure circuits can, and often do, override our seat of reason, the brain's frontal cortex, the professor said. In other words, stocks, like sex, sometimes drive us crazy. February 2, 2006.

NeuroInsights and BioToday Launch Neurotechnology Investment Newsletter in Japan.
News and analysis from NeuroInsights helps Japanese investors, companies, and researchers profit from advances in the brain industry. October, 2005.

MSNBC: No.1 Ranking for Bay Area in Neurotech.
In less than three years, Palo Alto's Jazz Pharmaceuticals Inc. has managed to rake in $265 million in equity financing, build up its employee base to 125 and fill its pipeline with seven drugs as it tries to break new ground in neurology and psychiatry. The start-up's quick ramp-up underscores some of the qualities that a new study says make the Bay Area the world's leading region for neurotechnology, an area that is rapidly gaining the attention of entrepreneurs and investors. August 21, 2005.

Silicon Valley Business Journal: Bay Area Top Market for Neurotechnology Industry.
NeuroInsights Neurotech Nexus Report lists the Bay Area as the leading market for investment, research and product development, followed by Boston, San Diego and London/Cambridge, England. August 15, 2005.

Venture Capital Journal: VCs are Psyched Over Brain Investments.
The venture business is famous for finding and funding the brainy and their ideas. Now the brain itself is becoming a hot area. One recent example: MPM Capital Partners was so crazy about psychiatric drug maker Somaxon Pharmaceuticals that it led a $65 million round in the company. August, 2005.

Seattle Times: Biotech Companies Scramble to Develop Brain Related Products.
"The demand for better cognitive therapeutics is exploding," concluded a study of the brain industry entitled The Neurotechnology Industry 2005 by NeuroInsights, a San Francisco research firm. August 5, 2005.

Mercury News: The Brain Business.
The prospect of a billion people nearing the age when they risk brain-related illnesses like Alzheimer's disease or chronic pain is helping fuel a costly scramble by biotechnology firms to find solutions. July, 2005.

Red Herring: Fast Facts- Money on the Brain.
According to NeuroInsights’ benchmark of 30 publicly traded neurotechnology companies, neurotech stocks grew 27 percent in 2004, compared to 11 percent and 9 percent growth for the S&P 500 and Nasdaq Composite Index, respectively. June, 2005.

NeuroInsights Reveals Brain Industry's Investment Opportunities, Risks and Competitive Landscape in New Industry-Defining Report. NeuroInsights, the neurotechnology market authority, today announced the release of the industry's first comprehensive investment- and business-focused analysis of the neurotechnology marketplace. May, 2005.

VCs have Brains on Their Mind: Neurotechnology Industry Experiencing Explosive Growth in Venture Funding Says Upcoming Report from NeuroInsights.
A soon-to-be-released report from NeuroInsights will show that venture capital investment in neurotech companies (firms developing treatments for neurological and psychiatric illnesses) climbed a phenomenal 225 percent from 1999 to 2004 -- representing $5.987 billion invested by VCs during that period. March, 2005.

Advance: The Mind's Eye: Imaging Helps Unravel Mysteries of the Brain.
If the 1990s were the "Decade of the Brain," these 10 years could be called the "Decade of Neuroimaging." With advances in technology, more scientists are using imaging to learn how the brain processes information. March, 2005.

Dubai News: Mental Health Will Be The Ultimate Business Weapon.
Providing a "Peek into 2050" noted futurologist, Zack Lynch, predicted that neurotechnology will be for the future what information technology is for the present. December, 2004.

CMO Magazine: Future Shock. Don't be surprised if these five technologies provide a jolt to the marketing profession. Zack Lynch discusses the future of neuromarketing in the premier issue of Chief Marketing Officer magazine. September, 2004.

American Way Magazine: Business on the Brain
Advanced MRI technology gives scientists a deeper understanding of how our brains think, feel and react. Could all this knowledge make us better marketers, managers, investors- even better human beings? (article not available online). August 15, 2004.

Adbusters: The Drive to Mastery
Zack Lynch explores the rise of neurofinance in Adbusters, a magazine with activist commentary from around the world addressing issues ranging from genetically modified foods to media concentration (article not available online). July/August, 2004.

Life Enhancement Magazine: The NeuroAge
A 14 page in-depth interview with Zack Lynch revealing how he became interested in neurotechnology and why you should be too. May, 2004.

U.S. News and World Report: Friday Forward: A Chat About Neurotechnology with Zack Lynch.
A discussion about the promise of neurotechnology for mental health treatment and other forward looking possibilities. May, 2004.

Annals of the New York Academy of Sciences: Neurotechnology and Society 2010-2060.
Zack Lynch writes a political economic prespective on the neurotechnology wave for a volume about "The Coevolution of Human Potential and Converging Technologies".Volume 1013: pp 229-233. May, 2004.

Australian National Radio: The Coming Neurosociety
It’s a brave new world of neuromarketing, neuroweapons and neuroethics. But who will have access to what’s on offer, and will your thoughts remain your own? Zack Lynch joins Natasha Mitchell as this week's feature guest. April, 2004.

Los Angeles Public Radio, KPFK: Digital Village
A 30 minute interview with Zack Lynch about the future of neurotechnology. March, 2004

The Lancet Neurology: Emotions in Art and the Brain
Zack Lynch covers the latest research from the International Conference on Neuroesthetics: Emotions in Art and the Brain (Subscription Required). March, 2004